VAMSI NUKALA
Allopathic & Osteopathic Physicians|Internal Medicine TARPON SPRINGS, FL NPI 1669737706
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL Penumbra, Inc. All categories
General Payments — all program years on this page
$8,111.28
- Category: General Payments
- Program years: PY2018–2024
- Record count: 355
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $296.16 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.16 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Penumbra, Inc. | $132.27 | 1 |
| Amgen Inc. | $80.24 | 4 |
| GlaxoSmithKline, LLC. | $24.96 | 1 |
| Acerta Pharma LLC | $20.88 | 1 |
| Exact Sciences Corporation | $19.72 | 1 |
| Lilly USA, LLC | $18.09 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1076218326 | Penumbra, Inc. | $132.27 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105528498 | AstraZeneca Pharmaceuticals LP | $20.88 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114812451 | Exact Sciences Corporation | $19.72 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116664659 | GlaxoSmithKline, LLC. | $24.96 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117643269 | Amgen Inc. | $21.78 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117643271 | Amgen Inc. | $14.95 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117643273 | Amgen Inc. | $26.02 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117643275 | Amgen Inc. | $17.49 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135473658 | Lilly USA, LLC | $18.09 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.